NO20082365L - Ny metode for fremstilling av 5-amino-3H-tiazolo[4,5-D]pyrimidin-2-on - Google Patents
Ny metode for fremstilling av 5-amino-3H-tiazolo[4,5-D]pyrimidin-2-onInfo
- Publication number
- NO20082365L NO20082365L NO20082365A NO20082365A NO20082365L NO 20082365 L NO20082365 L NO 20082365L NO 20082365 A NO20082365 A NO 20082365A NO 20082365 A NO20082365 A NO 20082365A NO 20082365 L NO20082365 L NO 20082365L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- thiazolo
- pyrimidin
- amino
- new method
- Prior art date
Links
- CGLJYFPRPQWKTN-UHFFFAOYSA-N 5-amino-3h-[1,3]thiazolo[4,5-d]pyrimidin-2-one Chemical compound NC1=NC=C2SC(=O)NC2=N1 CGLJYFPRPQWKTN-UHFFFAOYSA-N 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- YWBULOYFCXZCGF-UHFFFAOYSA-N [1,3]thiazolo[4,5-d]pyrimidine Chemical compound C1=NC=C2SC=NC2=N1 YWBULOYFCXZCGF-UHFFFAOYSA-N 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002519 immonomodulatory effect Effects 0.000 abstract 1
- 239000002718 pyrimidine nucleoside Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73805505P | 2005-11-21 | 2005-11-21 | |
| PCT/US2006/061111 WO2007062355A2 (en) | 2005-11-21 | 2006-11-20 | PROCESS FOR THE PREPARATION OF 5-AMINO-3H- THIAZOLO [4 , 5 -d] PYRIMIDIN- 2 -ONE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20082365L true NO20082365L (no) | 2008-08-18 |
Family
ID=37908057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20082365A NO20082365L (no) | 2005-11-21 | 2008-05-26 | Ny metode for fremstilling av 5-amino-3H-tiazolo[4,5-D]pyrimidin-2-on |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7781581B2 (pt) |
| EP (1) | EP1973920B1 (pt) |
| JP (1) | JP5117391B2 (pt) |
| KR (1) | KR20080090400A (pt) |
| CN (1) | CN101365705A (pt) |
| AR (1) | AR058210A1 (pt) |
| AT (1) | ATE474842T1 (pt) |
| AU (1) | AU2006318260B2 (pt) |
| BR (1) | BRPI0618789A2 (pt) |
| CA (1) | CA2630463C (pt) |
| DE (1) | DE602006015700D1 (pt) |
| EA (1) | EA200801404A1 (pt) |
| ES (1) | ES2345904T3 (pt) |
| IL (1) | IL191568A0 (pt) |
| NO (1) | NO20082365L (pt) |
| SG (1) | SG152296A1 (pt) |
| TW (1) | TWI383987B (pt) |
| WO (1) | WO2007062355A2 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101461604B1 (ko) | 2006-06-22 | 2014-11-18 | 애나디스 파마슈티칼스, 인코포레이티드 | 5-아미노-3-(3''-데옥시-β-Ｄ-리보퓨라노실)-티아졸로［4,5-ｄ］파이리미딘-2,7-다이온의 프로드럭 |
| WO2012102366A1 (ja) * | 2011-01-28 | 2012-08-02 | 日本たばこ産業株式会社 | 新規ピペラジン化合物の製造方法 |
| CN103012284A (zh) * | 2012-12-26 | 2013-04-03 | 无锡捷化医药科技有限公司 | 一种2-氨基-5-溴嘧啶类化合物的制备方法 |
| SG11201704512PA (en) | 2014-12-08 | 2017-07-28 | Hoffmann La Roche | 3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infection |
| CA3048768A1 (en) | 2017-01-06 | 2018-07-12 | F. Hoffmann-La Roche Ag | Process for the preparation of 3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione compounds |
| CN111635368B (zh) * | 2020-06-12 | 2021-06-29 | 东莞市东阳光仿制药研发有限公司 | 一种胺化合物的制备方法 |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4539205A (en) | 1982-11-09 | 1985-09-03 | Scripps Clinic And Research Foundation | Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives |
| US4643992A (en) | 1982-11-09 | 1987-02-17 | Scripps Clinic And Research Foundation | Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives |
| US5166141A (en) | 1983-11-01 | 1992-11-24 | Scripps Clinic And Research Foundation | Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-oxo-analogs of 8-substituted-guanine-9-(1'-beta-D-aldoglycosidyl) derivatives and methods of treating test animals |
| US4746651A (en) | 1983-11-01 | 1988-05-24 | Scripps Clinic And Research Foundation | Antimicrobial chemotherapeutic potentiation using substituted nucleoside derivatives |
| US5011828A (en) | 1985-11-15 | 1991-04-30 | Michael Goodman | Immunostimulating guanine derivatives, compositions and methods |
| GB8712745D0 (en) | 1987-05-30 | 1987-07-01 | Wellcome Found | Antiviral compounds |
| US4880784A (en) | 1987-12-21 | 1989-11-14 | Brigham Young University | Antiviral methods utilizing ribofuranosylthiazolo[4,5-d]pyrimdine derivatives |
| US5041426A (en) | 1987-12-21 | 1991-08-20 | Brigham Young University | Immune system enhancing 3-β-d-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and nucleotides |
| US5041542A (en) | 1988-06-03 | 1991-08-20 | Nucleic Acid Research Institute | Substituted pyrimido[5,4-d]pyrimidine nucleosides |
| GB9015914D0 (en) | 1990-07-19 | 1990-09-05 | Wellcome Found | Heterocyclic compounds |
| US5248672A (en) | 1990-11-01 | 1993-09-28 | The Regents Of The University Of Michigan | Polysubstituted benzimidazole nucleosides as antiviral agents |
| GB9105899D0 (en) | 1991-03-20 | 1991-05-08 | Wellcome Found | Therapeutic nucleosides |
| AU5165793A (en) | 1992-10-01 | 1994-04-26 | Mcneilab, Inc. | Derivatives of 7,8-disubstituted guanosines |
| GB9301000D0 (en) | 1993-01-20 | 1993-03-10 | Glaxo Group Ltd | Chemical compounds |
| US5395937A (en) | 1993-01-29 | 1995-03-07 | Minnesota Mining And Manufacturing Company | Process for preparing quinoline amines |
| US5994321A (en) | 1993-12-20 | 1999-11-30 | Aronex Pharmaceuticals, Inc. | Antiviral guanine analogs |
| US5446045A (en) | 1993-12-20 | 1995-08-29 | Revankar; Ganapathi R. | Antiviral guanine analogs |
| US5496816A (en) * | 1994-03-14 | 1996-03-05 | Merck & Co., Inc. | Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| ES2232871T3 (es) | 1996-07-03 | 2005-06-01 | Sumitomo Pharmaceuticals Company, Limited | Nuevos derivados de purina. |
| BR9714349A (pt) | 1996-10-16 | 2000-11-14 | Icn Pharmaceuticals | L-nucleosìdeos purina, seus análogos e utilizacões dos mesmos |
| US6509320B1 (en) | 1996-10-16 | 2003-01-21 | Icn Pharmaceuticals, Inc. | Purine L-nucleosides, analogs and uses thereof |
| IL129319A0 (en) | 1996-10-25 | 2000-02-17 | Minnesota Mining & Mfg | Immune response modifier compounds for treatment of TH2 mediated and related diseases |
| DE69817393T2 (de) | 1997-11-28 | 2004-06-17 | Sumitomo Pharmaceuticals Co., Ltd. | Neue heterozyklische verbindungen |
| TW572758B (en) | 1997-12-22 | 2004-01-21 | Sumitomo Pharma | Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives |
| JP2002510695A (ja) * | 1998-04-03 | 2002-04-09 | デュポン ファーマシューティカルズ カンパニー | 副腎皮質刺激ホルモン放出因子（ＣＲＦ）拮抗剤としてのチアゾロ［４，５−ｄ］ピリミジンおよびピリジン |
| US6444652B1 (en) | 1998-08-10 | 2002-09-03 | Novirio Pharmaceuticals Limited | β-L-2'-deoxy-nucleosides for the treatment of hepatitis B |
| US6664264B2 (en) | 2000-12-08 | 2003-12-16 | 3M Innovative Properties Company | Thioether substituted imidazoquinolines |
| US6667312B2 (en) | 2000-12-08 | 2003-12-23 | 3M Innovative Properties Company | Thioether substituted imidazoquinolines |
| US6545016B1 (en) | 2000-12-08 | 2003-04-08 | 3M Innovative Properties Company | Amide substituted imidazopyridines |
| US6545017B1 (en) | 2000-12-08 | 2003-04-08 | 3M Innovative Properties Company | Urea substituted imidazopyridines |
| US6664260B2 (en) | 2000-12-08 | 2003-12-16 | 3M Innovative Properties Company | Heterocyclic ether substituted imidazoquinolines |
| US20020086871A1 (en) | 2000-12-29 | 2002-07-04 | O'neill Brian Thomas | Pharmaceutical composition for the treatment of CNS and other disorders |
| US7157465B2 (en) | 2001-04-17 | 2007-01-02 | Dainippon Simitomo Pharma Co., Ltd. | Adenine derivatives |
| AP2004003069A0 (en) | 2001-11-27 | 2004-06-30 | Anadys Pharmaceuticals Inc | 3-beta-d-ribofuranosynthiazolo [4-5-d] pyridimine nucleosides and uses thereof. |
| US7321033B2 (en) * | 2001-11-27 | 2008-01-22 | Anadys Pharmaceuticals, Inc. | 3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof |
| US20040063658A1 (en) | 2002-05-06 | 2004-04-01 | Roberts Christopher Don | Nucleoside derivatives for treating hepatitis C virus infection |
| US7196090B2 (en) * | 2002-07-25 | 2007-03-27 | Warner-Lambert Company | Kinase inhibitors |
| US20050004144A1 (en) | 2003-04-14 | 2005-01-06 | Regents Of The University Of California | Combined use of IMPDH inhibitors with toll-like receptor agonists |
| US7585878B2 (en) * | 2003-06-12 | 2009-09-08 | Astellas Pharma Inc. | Benzamide derivative or salt thereof |
| JP2007504232A (ja) | 2003-09-05 | 2007-03-01 | アナディス ファーマシューティカルズ インク | Ｃ型肝炎ウイルス感染治療用のｔｌｒ７リガンド及びそのプロドラッグの投与 |
| US20050250820A1 (en) * | 2004-03-08 | 2005-11-10 | Amgen Inc. | Therapeutic modulation of PPARgamma activity |
| WO2006044775A2 (en) | 2004-10-15 | 2006-04-27 | Bayer Pharmaceuticals Corporation | Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity |
| US7560544B2 (en) * | 2004-12-17 | 2009-07-14 | Anadys Pharmaceuticals, Inc. | 3,5-Disubsitituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof |
| EP2392328A1 (en) | 2005-05-09 | 2011-12-07 | Hydra Biosciences, Inc. | Compounds for modulating TRPV3 Function |
| KR101461604B1 (ko) | 2006-06-22 | 2014-11-18 | 애나디스 파마슈티칼스, 인코포레이티드 | 5-아미노-3-(3''-데옥시-β-Ｄ-리보퓨라노실)-티아졸로［4,5-ｄ］파이리미딘-2,7-다이온의 프로드럭 |
| WO2008011406A2 (en) | 2006-07-18 | 2008-01-24 | Anadys Pharmaceuticals, Inc. | Carbonate and carbamate prodrugs of thiazolo [4,5-d] pyrimidines |
-
2006
- 2006-11-20 DE DE602006015700T patent/DE602006015700D1/de active Active
- 2006-11-20 BR BRPI0618789A patent/BRPI0618789A2/pt not_active IP Right Cessation
- 2006-11-20 KR KR1020087014973A patent/KR20080090400A/ko not_active Withdrawn
- 2006-11-20 AT AT06846356T patent/ATE474842T1/de not_active IP Right Cessation
- 2006-11-20 SG SG200903039-6A patent/SG152296A1/en unknown
- 2006-11-20 JP JP2008541505A patent/JP5117391B2/ja not_active Expired - Fee Related
- 2006-11-20 TW TW095142739A patent/TWI383987B/zh not_active IP Right Cessation
- 2006-11-20 WO PCT/US2006/061111 patent/WO2007062355A2/en not_active Ceased
- 2006-11-20 AU AU2006318260A patent/AU2006318260B2/en not_active Ceased
- 2006-11-20 CA CA2630463A patent/CA2630463C/en not_active Expired - Fee Related
- 2006-11-20 CN CNA200680050892XA patent/CN101365705A/zh active Pending
- 2006-11-20 ES ES06846356T patent/ES2345904T3/es active Active
- 2006-11-20 EA EA200801404A patent/EA200801404A1/xx unknown
- 2006-11-20 US US11/601,719 patent/US7781581B2/en not_active Expired - Fee Related
- 2006-11-20 EP EP06846356A patent/EP1973920B1/en not_active Not-in-force
- 2006-11-21 AR ARP060105089A patent/AR058210A1/es not_active Application Discontinuation
-
2008
- 2008-05-20 IL IL191568A patent/IL191568A0/en unknown
- 2008-05-26 NO NO20082365A patent/NO20082365L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE602006015700D1 (de) | 2010-09-02 |
| CA2630463A1 (en) | 2007-05-31 |
| KR20080090400A (ko) | 2008-10-08 |
| JP5117391B2 (ja) | 2013-01-16 |
| AU2006318260A1 (en) | 2007-05-31 |
| US20070117979A1 (en) | 2007-05-24 |
| WO2007062355A3 (en) | 2007-07-26 |
| ATE474842T1 (de) | 2010-08-15 |
| CN101365705A (zh) | 2009-02-11 |
| EP1973920B1 (en) | 2010-07-21 |
| EA200801404A1 (ru) | 2008-10-30 |
| EP1973920A2 (en) | 2008-10-01 |
| WO2007062355A2 (en) | 2007-05-31 |
| AR058210A1 (es) | 2008-01-23 |
| BRPI0618789A2 (pt) | 2016-08-30 |
| TWI383987B (zh) | 2013-02-01 |
| JP2009516709A (ja) | 2009-04-23 |
| US7781581B2 (en) | 2010-08-24 |
| ES2345904T3 (es) | 2010-10-05 |
| SG152296A1 (en) | 2009-05-29 |
| CA2630463C (en) | 2015-01-06 |
| IL191568A0 (en) | 2008-12-29 |
| TW200736265A (en) | 2007-10-01 |
| AU2006318260B2 (en) | 2012-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20074093L (no) | Fremgangsmater for fremstilling av glukopyranosyl-substituerte benzyl-benzenderivater og mellomprodukter derav | |
| NO20054404L (no) | 5,7-Diaminopyrazolo [4,3-D] Pyrimidiner Anvendelige ved behandling av of Hypertensjon | |
| WO2007035629A3 (en) | Process for the preparation of pyrimidinedione derivatives | |
| NO345018B1 (no) | Framgangsmåte for framstilling av organofluorforbindelser i alkoholholdige løsningsmidler. | |
| NO20081133L (no) | Tieno[2,3-B]-pyridin-5-karbonitriler som protein kinase inhibitorer | |
| WO2007023110A3 (en) | P38 map kinase inhibitors and methods for using the same | |
| EA200970519A1 (ru) | Полиморфы сукцината 2-[6-(3-аминопиперидин-1-ил)-3-метил-2,4-диоксо-3,4-дигидро-2h-пиримидин-1-илметил]-4-фторбензонитрил и способы их применения | |
| NO20080129L (no) | Fremgangsmate for fremstilling av dihydrokinazoliner | |
| WO2005021536A3 (en) | Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors | |
| EA200801381A1 (ru) | Производные пиримидина | |
| CL2007003459A1 (es) | Proceso de preparacion de compuestos derivados de pirimidina; y compuesto intermediario (s)-trans-etil 3-etoxi-7-(4-(4-fluorofenil)-6-isopropil-2-(n-metilmetilsulfonamido)pirimidin-5-il)-5-hidroxihep-2,6-dienoato. | |
| NO20082365L (no) | Ny metode for fremstilling av 5-amino-3H-tiazolo[4,5-D]pyrimidin-2-on | |
| WO2009006389A8 (en) | Pyrimidine derivatives useful as raf kinase inhibitors | |
| WO2007041130A3 (en) | Deazapurines useful as inhibitors of janus kinases | |
| NO20075232L (no) | Fremgangsmate for fremstilling av pyrido[2,3-d]pyrimidin-7-on og 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1 H)-on derivater | |
| GEP20135780B (en) | Novel pyrazolo [3,4-d] pyrimidine derivatives as anti-cancer agents | |
| WO2007092095A3 (en) | [4-(benzo [b] thi0phen-2-yl) pyrimidin-2yl] -amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases. | |
| WO2005076990A3 (en) | Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors | |
| WO2006087120A3 (de) | Pyrazolopyrimidine | |
| WO2006072612A3 (en) | Triazolophthalazines as pde2- inhibitors | |
| DK1838683T3 (da) | Fremgangsmåde til fremstilling af [1,4,5]-oxadiazepinderivater | |
| NO20073276L (no) | Metode for fremstilling av aminoetoksybenzylalkoholer | |
| WO2007070463A3 (en) | Compositions, methods and kits for removing debris from an ocular area | |
| WO2006079720A8 (fr) | Nouveaux derives d1oximes heterocycliques, leur procede de preparation et leur utilisation comme agents hypoglycemiants et hypoli pemiants | |
| TW200942546A (en) | A crystalline form of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |